- Client News
Cure Pharma launches chewable drug delivery system
CURE Pharmaceutical just announced the expansion of its oral drug delivery product line creating CUREform™ which includes CUREfilm®, one of…
News
- Client News
Thrive Global features CURE Pharmaceutical’s Jessica Rousset
CURE Pharmaceutical’s Jessica Rousset was interviewed by Thrive Global as a part of their series featuring accomplished women in STEM.…
- Client News
VC Reporter spotlights new board members and partnerships for CURE Pharmaceutical
CURE Pharmaceutical announces two new members to its board of directors. Lauren Chung, Ph.D., has 20 years of healthcare investment…
- Client News
CURE Pharmaceutical partners with Fytiko Farms
CURE Pharmaceutical reports on that it has signed a deal with hemp cultivation firm, Fytiko Farms. This partnership is projected…
- Client News
CURE Pharmaceutical secures patent on oral thin films
CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the allowance of U.S. Application No. 15/666,057, which…
- Client News
CURE Pharmaceutical partners with Canada’s Canopy Growth
CURE Pharmaceutical Holding Corp has entered into a partnership with Canadian cannabis giant Canopy Growth Corp to develop a CBD…
- Client News
CURE Pharmaceutical featured on Strategic Investor Radio
Listen to Rob Davidson, CEO of CURE Pharmaceutical and corporate board member for several companies in the industry, discuss this…
- Client News
CURE Pharmaceutical’s Jessica Rousset on PharmaVOICE’s “Woman of the Week” podcast
CURE Pharmaceutical’s Jessica Rousset was just featured on PharmaVOICE’s “Woman of the Week” podcast. “Jessica Rousset, a technologist, is not…
- Client News
CURE Pharmaceutical secures patent on oral thin film containing bioactive cannabinoid molecules
CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced the issuance of U.S. Patent No. 10,307,397, which covers…
- Client News
CURE Pharmaceutical expands leadership team
CURE Pharmaceutical (OTCQB:CURR) has announced four key hires to grow their leadership team. Michael Redard will serve as CURE’s Chief…